Controlling the Troll
IN RESPONSE:
Kalil and colleagues' meta-analysis of CMV management trials (1) is an important contribution to the literature that should be widely cited. The goal of my editorial was not to rephrase or critique their article, which can stand on its own merits. Rather, I hoped to communicate some historical perspective on the topic and discuss the current controversy between prophylactic and preemptive approaches to the management of CMV infection.
One concern I …
This 100-word excerpt has been provided in the absence of an abstract.
RSS Feeds









